Core B (Animal Component)
核心B(动物成分)
基本信息
- 批准号:10153758
- 负责人:
- 金额:$ 23.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adipose tissueAnimal ExperimentsAnimal HusbandryAnimalsBreedingCRISPR/Cas technologyCaringCellsCollaborationsDNADataDiseaseEmbryoEmbryo TransferEquipmentFOXO1A geneFeeding behaviorsFemaleFertilization in VitroFosteringFunctional disorderFundingGene TargetingGenerationsGenesGenetically Engineered MouseGenotypeGuidelinesHomeostasisHumanHuman ResourcesHypothalamic structureInstitutesKnock-inKnock-outLiverMaintenanceMediatingMediator of activation proteinMessenger RNAMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMethodologyMethodsMolecular TargetMusMutant Strains MiceNuclear ReceptorsOvulationPPAR alphaPPAR gammaPathway interactionsPhysiologicalProductionProgram EffectivenessProgram Research Project GrantsProtein IsoformsProteinsProtocols documentationRegulator GenesResearchResearch PersonnelResourcesRoleSTAT3 geneSavingsServicesSiteSystemTechnologyTherapeuticTimeTrainingTransgenesTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthVariantXBP1 geneanimal facilityanimal resourcebaseconditional knockoutcost effectivenessembryo cryopreservationembryonic stem cellexperienceexperimental analysisexperimental studygenotypic sexhomologous recombinationknock-downmalemouse genomemouse modelnuclear receptor coactivator 1operationoverexpressionpre-clinicalpreservationprogramssexsperm cryopreservationsuccesstranscription factor
项目摘要
Core B (Animal Component) - Project Summary
All research projects of this Program Project (PP) will rely on the use of genetically engineered mouse (GEM)
models to investigate the roles and mechanism of Nuclear Receptors, transcription factors and their coregulators
in energy and metabolic homeostasis and disease. More specifically, at least 34 GEM mouse lines will be used,
and thousands of male and female mice will be produced by breeding in house during the funding period of this
PP. Therefore, this Animal Component of Core B is essential for the success of this PP by integrating expensive
equipment, advanced technology, experienced personnel and animal resources. As shown by preliminary
studies, Core B has generated/established multiple GEM lines and developed CRISPR-Cas9-mediated mouse
gene editing systems. Core B is dedicated to achieving 3 major objectives. Firstly, Core B will use its specialized
expertise, state-of-the-art equipment and adequate facilities to generate GEM lines for all investigators of this
PP. Core B has established the necessary methods to edit the mouse genome by homologous recombination-
based gene targeting in ES cells or CRISPR/Cas9-based gene editing in 1-cell mouse embryos. Core B will
generate all GEM lines needed by the investigators of this PP. Secondly, Core B will provide high quality mouse
services to manage GEM line colonies and produce genotype-defined and age/sex-matched mice for all
investigators of this PP. Specifically, Core B will breed and maintain all of the 34 mouse lines used by this PP.
Core B will use our colony expansion protocol to produce large numbers of genotype/age/sex-matched mice for
experimental analysis. Core B also will perform genotype analysis, super ovulation, embryo and sperm
cryopreservation, and in vitro fertilization services to help the investigators of this PP for managing their mouse
colonies, preserving GEM lines, transferring mouse lines between institutes, and saving animal husbandry
expenses. Finally, Core B will integrate the efficient usage of animal resources by all investigators of this PP.
Because of the large-scale operation of mouse models and the sharing features of multiple mouse lines among
the projects of this PP, centralized integration of equipment, expertise and valuable mouse resource will be
essential for both scientific success and cost effectiveness. Core B will minimize the expenses of animal
experiments by consolidating the usage and management of equipment, expertise, animal facility, mouse
maintenance and production. In addition, Core B will serve as a resource for execution and technical training in
the use of all animal manipulations needed and oversee the care and use of experimental mice for this PP.
核心B(动物组成部分) - 项目摘要
该计划项目(PP)的所有研究项目都将依靠使用一般工程鼠标(GEM)的使用
研究核受体的作用和机制,转录因子和核心节的模型
能量和代谢稳态和疾病。更具体地说,将使用至少34条宝石鼠标线
在此资助期间,将通过闯入房屋来产生成千上万的雄性和雌性小鼠
pp。因此,核心B的这种动物成分对于通过整合昂贵的
设备,先进技术,经验丰富的人和动物资源。如初步所示
研究,核心B产生/建立了多个宝石线,并开发了CRISPR-Cas9介导的鼠标
基因编辑系统。核心B致力于实现3个主要目标。首先,核心B将使用其专业
专业知识,最先进的设备和足够的设施为所有研究人员生成宝石系列
pp。核心B已建立了通过同源重组编辑小鼠基因组的必要方法
1细胞胚胎中的ES细胞或基于CRISPR/CAS9的基因编辑基因靶向。核心核心
生成该PP的研究人员所需的所有宝石线。其次,核心B将提供高质量的鼠标
管理GEM系列颜色并为所有人生成基因型定义和年龄/性别匹配的小鼠的服务
该pp的研究者。具体而言,Core B将破坏并维护该PP使用的所有34条小鼠线。
核心B将使用我们的殖民地扩展方案来生产大量的基因型/年龄/性别匹配的小鼠
实验分析。核心B还将执行基因型分析,超级排卵,胚胎和精子
冷冻保存和体外受精服务,以帮助该PP的研究人员管理鼠标
殖民地,保存宝石线,在研究机构之间转移鼠标线,并保存畜牧业
开支。最后,核心B将整合该PP的所有研究人员对动物资源的有效使用。
由于鼠标模型的大规模操作以及多个鼠标线的共享特征
该PP,设备集中集成的项目,专业知识和宝贵的鼠标资源将是
科学成功和成本效益至关重要。核心B将最大程度地减少动物的费用
通过合并设备,专业知识,动物设施,鼠标的使用和管理来实验
维护和生产。此外,核心B将作为执行和技术培训的资源
使用所有动物操纵,并监督该PP实验小鼠的护理和使用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIANMING XU其他文献
JIANMING XU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIANMING XU', 18)}}的其他基金
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men
NCOA6 低表达在非裔美国男性前列腺癌差异中的主要作用
- 批准号:
10544740 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men
NCOA6 低表达在非裔美国男性前列腺癌差异中的主要作用
- 批准号:
10356340 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer
NCOA6,子宫内膜癌的新型肿瘤抑制因子
- 批准号:
9030156 - 财政年份:2015
- 资助金额:
$ 23.78万 - 项目类别:
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer
NCOA6,子宫内膜癌的新型肿瘤抑制因子
- 批准号:
10057354 - 财政年份:2015
- 资助金额:
$ 23.78万 - 项目类别:
相似国自然基金
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
羊膜间充质干细胞联合水凝胶支架材料移植干预脊髓损伤动物实验研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
深渊片脚类动物原位代谢测量与高质量实验技术研究
- 批准号:42276191
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
节肢动物病毒多样性的生态驱动因素研究:以新岗山生态系统功能实验基地为例
- 批准号:32200004
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
羊膜间充质干细胞联合水凝胶支架材料移植干预脊髓损伤动物实验研究
- 批准号:82271408
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
相似海外基金
Modernization of Small Animal Caging for infectious disease studies at the Boise VAMC
博伊西 VAMC 用于传染病研究的小动物笼舍现代化
- 批准号:
10734738 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Animal Carcinogenesis Core - Developmental Funds
动物致癌核心 - 发展基金
- 批准号:
8369407 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
Dissecting expression divergence in developmental networks across Drosophilids
剖析果蝇发育网络中的表达差异
- 批准号:
8535183 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
Dissecting expression divergence in developmental networks across Drosophilids
剖析果蝇发育网络中的表达差异
- 批准号:
8351015 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别: